bibliographic entry 2492560 [be/2492560]
https://w3id.org/oc/corpus/be/2492560

is a

• bibliographic reference

content

• Merck Sharp & Dohme, Cardiovascular outcomes following treatment with ertugliflozin in participants with type 2 diabetes mellitus and established vascular disease: the VERTIS CV Study (MK-8835-004), Available from, https://www.clinicaltrials.gov/ct2/show/record/NCT01986881. NLM identifier: NCT01986881, Accessed January 8, 2016

references

• https://w3id.org/oc/corpus/br/2769153